We are live on ! Find out more
BIOA

BioAge Labs
BIOA

83 hedge funds and large institutions have $85.6M invested in BioAge Labs in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

24% more funds holding

Funds holding: 67 → 83 (+16)

12% more capital invested

Capital invested by funds: $76.2M → $85.6M (+$9.4M)

1.22% more ownership

Funds ownership: 56.57% → 57.79% (+1.2%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.26M

Holders
83
Holders Change
+16
Holders Change %
+23.88%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
25
Increased
31
Reduced
9
Closed
9
Calls
–
Puts
$1.26M
Net Calls
-$1.26M
Net Calls Change
-$496K

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$3.89M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.46M
3
BlackRock
BlackRock
New York
+$2.3M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.1M
5
CF
Cantor Fitzgerald
New York
+$806K

Top Sellers

Rank Fund Capital Flow
1
SCM
Suvretta Capital Management
New York
-$5.46M
2
RCM
RA Capital Management
Massachusetts
-$3.96M
3
RI
RTW Investments
New York
-$2.96M
4
CAM
Cormorant Asset Management
Massachusetts
-$1.97M
5
HHMI
Howard Hughes Medical Institute
Maryland
-$428K
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$278K +$272K +67,398 New
Two Sigma Investments
27
Two Sigma Investments
New York
$267K +$199K +49,456 +327%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$258K +$252K +62,501 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$223K +$131K +32,436 +151%
PCM
30
Prelude Capital Management
New York
$219K +$144K +35,639 +204%
BCM
31
Bridgeway Capital Management
Texas
$217K +$212K +52,600 New
JFG
32
Jefferies Financial Group
New York
$207K +$201K +50,000 New
Ameriprise
33
Ameriprise
Minnesota
$182K +$177K +44,034 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$178K +$66.9K +16,598 +63%
MCP
35
Militia Capital Partners
Nevada
$166K +$162K +40,300 New
Barclays
36
Barclays
United Kingdom
$165K +$110K +27,234 +214%
Millennium Management
37
Millennium Management
New York
$149K +$145K +36,073 New
WP
38
Woodline Partners
California
$130K – – –
AQR Capital Management
39
AQR Capital Management
Connecticut
$130K +$127K +31,552 New
N
40
Nuveen
North Carolina
$127K -$99.2K -24,612 -44%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$124K +$81.9K +20,336 +208%
Deutsche Bank
42
Deutsche Bank
Germany
$105K +$72.8K +18,071 +249%
Goldman Sachs
43
Goldman Sachs
New York
$102K -$7.92K -1,967 -7%
UBS Group
44
UBS Group
Switzerland
$94.6K +$20.6K +5,109 +29%
SO
45
STRS Ohio
Ohio
$87.1K -$52.4K -13,000 -38%
Walleye Capital
46
Walleye Capital
New York
$64K +$62.4K +15,493 New
Simplex Trading
47
Simplex Trading
Illinois
$63K -$25.5K -6,322 -29%
Wells Fargo
48
Wells Fargo
California
$62.9K +$35.4K +8,778 +136%
VF
49
Virtu Financial
New York
$62K +$60.1K +14,911 New
IIM
50
INTECH Investment Management
Florida
$60.2K +$58.7K +14,567 New
1
2
3 4

BIOA Hedge Fund Activity: Q2 2025 in Review

83 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q2 2025, worth a combined $85.6M — up 12% from $76.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIOA positions and 9 closed out — a net gain of 16 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was ADAR1 Capital Management, adding an estimated $3.89M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.46M sold.

  • 83 institutional investors held BioAge Labs (BIOA) as of Q2 2025, up from 67 in Q1 2025.
  • Funds reported $85.6M of BioAge Labs stock for Q2 2025, up 12% quarter-over-quarter.
  • 25 funds opened new BioAge Labs positions in Q2 2025 and 9 closed out, a net change of +16 holders.
  • The largest BioAge Labs buyer in Q2 2025 was ADAR1 Capital Management, an estimated $3.89M added.
  • The largest BioAge Labs seller in Q2 2025 was Suvretta Capital Management, an estimated $5.46M sold.

Based on aggregated 13F filings for Q2 2025.